Intra Cellular Therapies shares owned by Suvretta Capital Management
Quarter-by-quarter ownership of Intra Cellular Therapies (ITCI) shares owned by Suvretta Capital Management
from 13F filings
Historical chart of Suvretta Capital Management investment in Intra Cellular Therapies
Tip: Access up to 7 years of quarterly data
All positions including Intra Cellular Therapies held by Suvretta Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Intra Cellular Therapies by Suvretta Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-06-30 | $107M | 1.6M | 68.49 |
| 2024-03-31 | $66M | 959k | 69.20 |
| 2023-09-30 | $71M | 1.4M | 52.09 |
| 2023-06-30 | $76M | 1.2M | 63.32 |
| 2023-03-31 | $65M | 1.2M | 54.15 |
| 2022-12-31 | $55M | 1.0M | 52.92 |
| 2022-09-30 | $40M | 852k | 46.53 |
| 2022-06-30 | $76M | 1.3M | 57.08 |
| 2022-03-31 | $94M | 1.5M | 61.19 |
| 2021-12-31 | $66M | 1.3M | 52.34 |
| 2021-09-30 | $47M | 1.3M | 37.28 |
| 2021-06-30 | $42M | 1.0M | 40.82 |
| 2021-03-31 | $35M | 1.0M | 33.93 |
| 2020-12-31 | $29M | 906k | 31.80 |
| 2020-09-30 | $13M | 492k | 25.66 |
More positions owned by Suvretta Capital Management
View all positions for Suvretta Capital Management